While the most logical conclusion from these studies is that a loss of target-derived BDNF neurotrophic support contributes to the neurodegeneration in ALS, which would provide a rationale for the use of BDNF clinically, several studies raise further questions. The gene discussed is BDNF; the disease is amyotrophic lateral sclerosis.